Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Expire on May on 2020??
They expire in May of 2020 exercise price is approx $6.25 not sure of the exact number could be $6.20.
I'm seeking information about the warrants. nDRAW
I own some warrants from a few years ago. I had medical problems for about 1 1/2 years and am back trying to get into problems in my portfolio.
I have a great deal of trouble with the NDRA website.
Thanks in advamce fpr amy website or source of information about these warrants outstanding ...anything about their term length, expiration dates, or assistance of any type.
TIA
I watched but saw nothing….what did I miss??
Feel like NDRA has always been pretty active pre & post market and I've been a holder for 4 years or so. What are you inferring when you saw watch it pre & post?
Watch for action in the pre and post markets.
$NDRA/$NDRAW
Good for you. I’m with the rest of the world and will wait until until they can independently prove that it works.
we all have are opinion on when to buy. I am 2x here so I am happy.
dnd, that is well and good, but what one or two institutions do doesn’t mean much. Institutional ownership has been below 9% for the last five years, so they are not buying the story yet. I think waiting for measurable validation is prudent. They will be plenty of time to buy after that.
Vanguard bought 1.5M last qtr along with several other big purchases. One big seller who took a quick 3X from the offering in December.
Only 9% institutional ownership. Should be much, much higher if they believed..
lots of cash on hand.
no dilution needed in the next 12 months .
510k approval should be any day.
What’s everyone’s takeaway from the recent quarterly releases today?
Nice scoooooooop
Got my long awaited fill at $2.05 today. Now ready for the next move up.
Downward pressure today which is interesting given how the NASDAQ is taking off?! Just found this article from 3/31 as well:
https://pennystocks.com/featured/2021/03/31/4-penny-stocks-to-watch-before-look-blue-chips/
Awesome, love it!
Review the transcript from the 3/25. After I reviewed it I would say the answer to your question is NO.
Do they need data from the recent university partnership studies in order to obtain FDA approval?
I am FDA approval anyday, more drug partnerships, more patents, and sales. Double digits are coming.
Looking at the chart you could be right if we get one of those tails like we have seen twice before.
I think $2.10 is rock bottom
I want to get some more on the low 2s too
Call me greedy but I'm hoping for a pullback near 2 bucks
Huge endorsement & derisking event for NDRA & their TAEUS technology.
Hepion Pharma commits to using TAEUS in their critical Phase 2b NASH study even though TAEUS has not received FDA 510k Clearance yet??? Unprecedented IMO. This is strong evidence of just large the market for TAEUS will be...
Consider the opinion of someone who is not long NDRA but has done his due diligence. In fact, he is the CEO of another company. And he is bullish on TAEUS:
"Hepion Pharma is excited to incorporate ENDRA's technology into screening for our Phase 2b study of CRV431, which targets non-alcoholic steatohepatitis (NASH) and other liver diseases," said Hepion's CEO Dr. Robert Foster."
"... there is enormous potential value in capturing data on the degree of hepatic steatosis and other biomarkers to refine our understanding of systemic variables associated with NAFLD-NASH. We believe ENDRA's TAEUS system is uniquely designed to accomplish this task for us."
http://investors.endrainc.com/prviewer/release_only/id/4662746
ENDRA Life Sciences to Report Fourth Quarter 2020 Financial Results on March 25, 2021
https://finance.yahoo.com/news/endra-life-sciences-report-fourth-200500452.html
Nice collaboration announcement... LFG!!!!
https://finance.yahoo.com/news/endra-life-sciences-hepion-pharmaceuticals-120000579.html
Funny they hadn’t even submitted there application to the FDA one year ago!
Funny, we said the same thing one year ago
Technically there were insiders purchasing because at least half reached into their own pockets to cover taxes on shares versus selling shares to cover those same taxes.
The average time for this type of devices is 8 months. I'm expecting it by the end of this month hopefully if there's no delay due to covid.
Gotcha. Well fingers crossed these research partners are impressed with the accuracy. Also I keep checking insider trading and only automatic sells in the last 3 months which is good. No purchases though.
You have all the information that is out there at this point.
I've been bullish on Endra for a couple years now, but as we await further news about FDA and in light of the recent Colorado and European university collaborations, do you guys recall seeing any independent data showing TAEUS efficacy compared to the current standard of care (MRI)? Is there any possibility that these universities come back and say, "Nope, sorry your product is not sufficient at determining liver fat in an acceptable manner"? I do recall seeing something that they had data based on their protoype and ENDRA saying that the commercialized product would be even better and more accurate than their prototype.
Any day the sky turns blue.
https://www.accesswire.com/630080/ENDRA-Life-Sciences-Announces-New-Clinical-Study-Partnership-with-Inselspital-University-Hospital-in-Bern-Switzerland I know it is a couple of weeks old but still good news!
Got me 12k shares maybe 13k for luck. Stalking this biatch for a month 321 like my number lol
What’s that you say up sharply?
Bet you would rather be in NDRA today then our other stock.
Followers
|
52
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1262
|
Created
|
10/24/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |